<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03956030</url>
  </required_header>
  <id_info>
    <org_study_id>STUDY00012248</org_study_id>
    <nct_id>NCT03956030</nct_id>
  </id_info>
  <brief_title>Effect of Formal Contraception Handouts</brief_title>
  <official_title>Effect of Formal Contraception Handouts on Postpartum Birth Control Use and Methods</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Milton S. Hershey Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Milton S. Hershey Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The hypothesis of this study is to determine if distribution of a standardized educational&#xD;
      handout on contraceptive options given to patients in the prenatal office setting will&#xD;
      increase contraception use six months postpartum.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Reducing unintended pregnancies and those that are conceived within 18 months of a previous&#xD;
      livebirth is an important health concern in the United States. Both unintended and&#xD;
      close-interval pregnancies constitute 40% and 35% of pregnancies in the United States&#xD;
      respectively with some overlap between the two categories and are associated with adverse&#xD;
      maternal and fetal outcomes. A national survey found that 17.8% of women using&#xD;
      'less-effective' methods and 23% of women using no birth control became pregnant in â‰¤18&#xD;
      months2. Access to better contraception education could potentially decrease the proportion&#xD;
      of unintended pregnancies and close-interval pregnancies. In addition to the health concerns,&#xD;
      58% of women in the US would like more information about contraceptive options, and organized&#xD;
      handouts on birth control have been shown to contribute to the choice in birth control.&#xD;
      However, there has been conflicting evidence about which educational methods increase&#xD;
      postpartum contraception use. Therefore, the investigators propose a randomized controlled&#xD;
      trial (RCT) that assesses whether a handout on contraception options increases postpartum&#xD;
      birth control use. The control group would receive a nutrition handout, and the intervention&#xD;
      group would receive a handout on birth control options in addition to each receiving the&#xD;
      standard of care. The researchers would also give pre- and post-natal questionnaires,&#xD;
      covering patient satisfaction, intention to use birth control, and how often a provider&#xD;
      discusses birth control options.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 10, 2020</start_date>
  <completion_date type="Anticipated">December 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized controlled trial in which the intervention group will receive an educational handout on contraception and the control group will receive a handout on nutrition.</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Contraception Use</measure>
    <time_frame>8 weeks postpartum</time_frame>
    <description>Contraception use defined as yes or no (as reported by the patient)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Contraception Use</measure>
    <time_frame>6 months postpartum</time_frame>
    <description>Contraception use defined as yes or no (as reported by the patient)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Contraception</condition>
  <condition>Counseling</condition>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intervention group will receive educational handout on contraception.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Control group will receive educational handout on nutrition.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Contraception Handout</intervention_name>
    <description>Handout covering contraception options</description>
    <arm_group_label>Intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Nutritional Handout</intervention_name>
    <description>Handout covering nutrition</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Women who are pregnant and are 24-28 weeks gestational age at the time of recruitment&#xD;
&#xD;
          2. Women &gt;18 years of age&#xD;
&#xD;
          3. Women with low-risk pregnancies&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Women who receive prenatal care by the Maternal Fetal Medicine department for&#xD;
             high-risk pregnancies&#xD;
&#xD;
          2. Women who are members of an at-risk population including any women who is a prisoner,&#xD;
             cannot provide consent, or is &lt;18 years of age&#xD;
&#xD;
          3. Non-English speaking&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>This study will recruit women who are 24-28 weeks gestational age.</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christina DeAngelis, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Milton S. Hershey Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Matthew Fore, MD</last_name>
    <phone>717-531-8521</phone>
    <email>mfore@pennstatehealth.psu.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Women's Health Center</name>
      <address>
        <city>Hershey</city>
        <state>Pennsylvania</state>
        <zip>17033</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christina DeAngelis, MD</last_name>
      <phone>717-531-3505</phone>
      <email>cdeangelis2@pennstatehealth.psu.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>May 16, 2019</study_first_submitted>
  <study_first_submitted_qc>May 16, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 20, 2019</study_first_posted>
  <last_update_submitted>December 10, 2020</last_update_submitted>
  <last_update_submitted_qc>December 10, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 11, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Milton S. Hershey Medical Center</investigator_affiliation>
    <investigator_full_name>Christina DeAngelis</investigator_full_name>
    <investigator_title>Assistant Professor Women's Health Division</investigator_title>
  </responsible_party>
  <keyword>Female Contraception</keyword>
  <keyword>Education</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

